|Bid||3.6500 x 800|
|Ask||3.8400 x 1800|
|Day's Range||3.6000 - 3.8400|
|52 Week Range||3.1500 - 53.2000|
|Beta (3Y Monthly)||3.34|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
EDEN PRAIRIE, Minn., March 12, 2019 -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of $12.42.
CHF Solutions, Inc. (CHFS) today announced the pricing of an underwritten public offering of units for gross proceeds of approximately $10.8 million prior to deducting underwriting discounts and commissions and offering expenses payable by CHF Solutions. The conversion price of the preferred stock issued in the transaction as well as the exercise price of the warrants are fixed and do not contain any variable pricing features or any price based anti-dilutive features.
EDEN PRAIRIE, Minn., March 01, 2019 -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019, the independent directors approved five equity.
We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! The big shareholder groups in CHF Solutions, Inc. (NASDAQ:CHFS) haveRead More...
EDEN PRAIRIE, Minn., Feb. 20, 2019 -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2018, which included the.
EDEN PRAIRIE, Minn., Feb. 19, 2019 -- CHF Solutions (Nasdaq: CHFS), today announced the initiation of a distribution agreement in the Brazilian market with Bragenix, LTDA..
EDEN PRAIRIE, Minn., Feb. 13, 2019 -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter and year-end 2018 financial results will be released on.
CHF Solutions (CHFS), today announced the initiation of a distribution agreement in the Indian market with Wayinia Lifesciences. This agreement expands the company’s sales outreach in Asia, while opening new access to one of the larger population centers in the region. Currently, there are around three million reports of heart failure in India, with an additional one million new incidents being reported annually. Wayinia Lifesciences was established in 2015 with roots from India and Norway.
EDEN PRAIRIE, Minn., Jan. 24, 2019 -- CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a breakfast symposium at the Society of Thoracic Surgeons Annual.
CHF Solutions (CHFS) today announced the filing of two new patent applications with the United States Patent and Trademark Office (USPTO) designed to deepen the company’s intellectual property protection for its Aquadex FlexFlow system. One of the two applications is based on the company’s design for a wearable device designed to assist in maintaining peripheral venous blood flow access in the arm during aquapheresis treatment with the Aquadex FlexFlow system. The second application includes multiple potential new features and improvements to the diagnostic capabilities of the Aquadex FlexFlow system, which, if incorporated into the product, would be designed to help ensure optimal patient fluid balance and to dramatically improve usability for healthcare providers.
EDEN PRAIRIE, MN / ACCESSWIRE / November 28, 2018 / CHF Solutions (NASDAQ: CHFS), today announced that it will be presenting at the 11th annual LD Micro Main Event on Wednesday, December 5th at 7:30AM ...
EDEN PRAIRIE, Minn., Nov. 15, 2018 -- CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles, M.D., Ph.D.,.
CHF Solutions, Inc. (CHFS), today announced that it will release an educational webinar featuring the clinical use of the Aquadex FlexFlow system following cardiovascular surgery in patients who have failed diuretic therapy. The webinar will be viewable on the company’s website, https://www.chf-solutions.com/aquapheresis-training-program/ on November 15, 2018 beginning at 12:00 PM ET.
EDEN PRAIRIE, Minn., Nov. 06, 2018 -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today its third quarter results for the period ended September 30, 2018. Highlights include:.
CHF Solutions, Inc. (CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (DXR) to explore potential synergies between the company’s Aquadex FlexFlow® System and Daxor’s BVA-100 Blood Volume Analyzer. The company believes that the two technologies can be used together to assess a patient’s fluid volume status and assist in informing on the clinical management of a fluid overloaded patient.
EDEN PRAIRIE, Minn., Oct. 30, 2018 -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2018 financial results will be released on Tuesday, November 6,.